The joint Letter of Intent requests NRC consent under 10 CFR 40.46 for the transfer of control of License SUB-1011 from Radnostix and its subsidiary International Isotopes Fluorine Products, Inc. to ...
Nuclear medicine therapy involves delivering radiation-emitting drugs directly inside the body to treat refractory cancers.
Telix Pharmaceuticals Limited and Ekalia announced a collaboration to advance scalable United States (U.S.) production of astatine-211 (211At), an alpha-emitting radioisotope being investigated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results